Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Keiser

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature Communications|May 19, 2025
Optimized AAV capsids for basal ganglia diseases show robust potency and distributionD E Leib, Y H Chen, L Tecedor, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Nature Medicine|October 19, 2021
Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brainMegan S Keiser, Paul T Ranum, Carolyn M Yrigollen, et al.
Arxiv|November 24, 2025
Low-N Protein Activity Optimization with FolDEJacob B Roberts, Catherine R Ji, Isaac Donnell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature Communications|May 19, 2025
Optimized AAV capsids for basal ganglia diseases show robust potency and distributionD E Leib, Y H Chen, L Tecedor, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Nature Medicine|October 19, 2021
Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brainMegan S Keiser, Paul T Ranum, Carolyn M Yrigollen, et al.
Arxiv|November 24, 2025
Low-N Protein Activity Optimization with FolDEJacob B Roberts, Catherine R Ji, Isaac Donnell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Pageof 6